<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d227" origId="Carbinoxamine"><sentence id="DrugDDI.d227.s0" origId="s0" text="Antihistamines may enhance the effects of tricyclic antidepressants, barbiturates, alcohol, and other CNS depressants."><entity id="DrugDDI.d227.s0.e0" origId="s0.p0" charOffset="0-14" type="drug" text="Antihistamines"/><entity id="DrugDDI.d227.s0.e1" origId="s0.p4" charOffset="42-67" type="drug" text="tricyclic antidepressants"/><entity id="DrugDDI.d227.s0.e2" origId="s0.p5" charOffset="69-81" type="drug" text="barbiturates"/><entity id="DrugDDI.d227.s0.e3" origId="s0.p6" charOffset="83-90" type="drug" text="alcohol"/><entity id="DrugDDI.d227.s0.e4" origId="s0.p8" charOffset="102-117" type="drug" text="CNS depressants"/><pair id="DrugDDI.d227.s0.p0" e1="DrugDDI.d227.s0.e0" e2="DrugDDI.d227.s0.e1" interaction="true"/><pair id="DrugDDI.d227.s0.p1" e1="DrugDDI.d227.s0.e0" e2="DrugDDI.d227.s0.e2" interaction="true"/><pair id="DrugDDI.d227.s0.p2" e1="DrugDDI.d227.s0.e0" e2="DrugDDI.d227.s0.e3" interaction="true"/><pair id="DrugDDI.d227.s0.p3" e1="DrugDDI.d227.s0.e0" e2="DrugDDI.d227.s0.e4" interaction="true"/><pair id="DrugDDI.d227.s0.p4" e1="DrugDDI.d227.s0.e1" e2="DrugDDI.d227.s0.e2" interaction="false"/><pair id="DrugDDI.d227.s0.p5" e1="DrugDDI.d227.s0.e1" e2="DrugDDI.d227.s0.e3" interaction="false"/><pair id="DrugDDI.d227.s0.p6" e1="DrugDDI.d227.s0.e1" e2="DrugDDI.d227.s0.e4" interaction="false"/><pair id="DrugDDI.d227.s0.p7" e1="DrugDDI.d227.s0.e2" e2="DrugDDI.d227.s0.e3" interaction="false"/><pair id="DrugDDI.d227.s0.p8" e1="DrugDDI.d227.s0.e2" e2="DrugDDI.d227.s0.e4" interaction="false"/><pair id="DrugDDI.d227.s0.p9" e1="DrugDDI.d227.s0.e3" e2="DrugDDI.d227.s0.e4" interaction="false"/></sentence><sentence id="DrugDDI.d227.s1" origId="s1" text="MAO inhibitors prolong and intensify the anticholinergic effects of antihistamines."><entity id="DrugDDI.d227.s1.e0" origId="s1.p9" charOffset="0-14" type="drug" text="MAO inhibitors"/><entity id="DrugDDI.d227.s1.e1" origId="s1.p13" charOffset="41-56" type="drug" text="anticholinergic"/><entity id="DrugDDI.d227.s1.e2" origId="s1.p14" charOffset="68-82" type="drug" text="antihistamines"/><pair id="DrugDDI.d227.s1.p0" e1="DrugDDI.d227.s1.e0" e2="DrugDDI.d227.s1.e1" interaction="false"/><pair id="DrugDDI.d227.s1.p1" e1="DrugDDI.d227.s1.e0" e2="DrugDDI.d227.s1.e2" interaction="true"/><pair id="DrugDDI.d227.s1.p2" e1="DrugDDI.d227.s1.e1" e2="DrugDDI.d227.s1.e2" interaction="false"/></sentence><sentence id="DrugDDI.d227.s2" origId="s2" text="Sympathomimetic amines may reduce the antihypertensive effects of reserpine, veratrum alkaloids, methyldopa and mecamylamine."><entity id="DrugDDI.d227.s2.e0" origId="s2.p15" charOffset="0-22" type="drug" text="sympathomimetic amines"/><entity id="DrugDDI.d227.s2.e1" origId="s2.p18" charOffset="38-54" type="drug" text="antihypertensive"/><entity id="DrugDDI.d227.s2.e2" origId="s2.p19" charOffset="66-75" type="drug" text="reserpine"/><entity id="DrugDDI.d227.s2.e3" origId="s2.p20" charOffset="77-95" type="drug" text="veratrum alkaloids"/><entity id="DrugDDI.d227.s2.e4" origId="s2.p21" charOffset="97-107" type="drug" text="methyldopa"/><entity id="DrugDDI.d227.s2.e5" origId="s2.p23" charOffset="112-124" type="drug" text="mecamylamine"/><pair id="DrugDDI.d227.s2.p0" e1="DrugDDI.d227.s2.e0" e2="DrugDDI.d227.s2.e1" interaction="false"/><pair id="DrugDDI.d227.s2.p1" e1="DrugDDI.d227.s2.e0" e2="DrugDDI.d227.s2.e2" interaction="true"/><pair id="DrugDDI.d227.s2.p2" e1="DrugDDI.d227.s2.e0" e2="DrugDDI.d227.s2.e3" interaction="true"/><pair id="DrugDDI.d227.s2.p3" e1="DrugDDI.d227.s2.e0" e2="DrugDDI.d227.s2.e4" interaction="true"/><pair id="DrugDDI.d227.s2.p4" e1="DrugDDI.d227.s2.e0" e2="DrugDDI.d227.s2.e5" interaction="true"/><pair id="DrugDDI.d227.s2.p5" e1="DrugDDI.d227.s2.e1" e2="DrugDDI.d227.s2.e2" interaction="false"/><pair id="DrugDDI.d227.s2.p6" e1="DrugDDI.d227.s2.e1" e2="DrugDDI.d227.s2.e3" interaction="false"/><pair id="DrugDDI.d227.s2.p7" e1="DrugDDI.d227.s2.e1" e2="DrugDDI.d227.s2.e4" interaction="false"/><pair id="DrugDDI.d227.s2.p8" e1="DrugDDI.d227.s2.e1" e2="DrugDDI.d227.s2.e5" interaction="false"/><pair id="DrugDDI.d227.s2.p9" e1="DrugDDI.d227.s2.e2" e2="DrugDDI.d227.s2.e3" interaction="false"/><pair id="DrugDDI.d227.s2.p10" e1="DrugDDI.d227.s2.e2" e2="DrugDDI.d227.s2.e4" interaction="false"/><pair id="DrugDDI.d227.s2.p11" e1="DrugDDI.d227.s2.e2" e2="DrugDDI.d227.s2.e5" interaction="false"/><pair id="DrugDDI.d227.s2.p12" e1="DrugDDI.d227.s2.e3" e2="DrugDDI.d227.s2.e4" interaction="false"/><pair id="DrugDDI.d227.s2.p13" e1="DrugDDI.d227.s2.e3" e2="DrugDDI.d227.s2.e5" interaction="false"/><pair id="DrugDDI.d227.s2.p14" e1="DrugDDI.d227.s2.e4" e2="DrugDDI.d227.s2.e5" interaction="false"/></sentence><sentence id="DrugDDI.d227.s3" origId="s3" text="Effects of sympathomimetics are increased with MAO inhibitors and beta adrenergic blockers."><entity id="DrugDDI.d227.s3.e0" origId="s3.p25" charOffset="11-27" type="drug" text="sympathomimetics"/><entity id="DrugDDI.d227.s3.e1" origId="s3.p28" charOffset="47-61" type="drug" text="MAO inhibitors"/><entity id="DrugDDI.d227.s3.e2" origId="s3.p30" charOffset="66-90" type="drug" text="beta adrenergic blockers"/><pair id="DrugDDI.d227.s3.p0" e1="DrugDDI.d227.s3.e0" e2="DrugDDI.d227.s3.e1" interaction="true"/><pair id="DrugDDI.d227.s3.p1" e1="DrugDDI.d227.s3.e0" e2="DrugDDI.d227.s3.e2" interaction="true"/><pair id="DrugDDI.d227.s3.p2" e1="DrugDDI.d227.s3.e1" e2="DrugDDI.d227.s3.e2" interaction="false"/></sentence></document>